Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 19 sie 2019 · We found 246 medical malpractice cases related to the acute management of ischemic stroke and 26 related to intracranial hemorrhage. Seventy-one cases specifically alleged a failure to treat with tPA (tissue-type plasminogen activator) and 7 cases alleged a failure to treat, or to timely treat, with thrombectomy.

  2. 14 kwi 2022 · Intracerebral hemorrhage (ICH) is a devastating form of stroke with high morbidity and mortality. This review article focuses on the epidemiology, cause, mechanisms of injury, current treatment strategies, and future research directions of ICH. Incidence of hemorrhagic stroke has increased worldwide over the past 40 years, with shifts in the ...

  3. 15 paź 2020 · Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.

  4. 1 maj 2023 · Differential Diagnosis. In addition to the direct effects of the stroke, cognitive function after stroke can be affected by other stroke complications (eg, hyponatremia, delirium, depression), as well as by prestroke cognitive decline and coexisting age-related neuropathologies.

  5. 14 kwi 2019 · Although neurologists consider intravenous tissue plasminogen activator (tPA) to be standard of care in the treatment of patients with acute ischemic stroke, its use remains contentious within the broader medical community, and particularly among emergency physicians. Why might this be?

  6. 13 maj 2021 · Accurate diagnosis of stroke/TIA to prevent stroke chameleons, false-negative stroke cases, is essential to assure appropriate stroke treatment and prevention strategies are initiated regardless of the care setting.

  7. 4 mar 2024 · A clear understanding of the causes and pathophysiology of ischemic stroke presents a unique opportunity for the development of a pool of potential therapies for the condition. In this review, we dive deep into ischemic stroke pathophysiology and identify possible targets for novel therapies including cellular therapies.

  1. Ludzie szukają również